Last reviewed · How we verify

NCT04217525: DSOS

Duke Spine Outcome Study (DSOS)

Suspended Last updated 20 January 2026
What this trial tests

trial in Spinal Tumor in 900 participants. Suspended.

Timeline
3 December 2019
Primary endpoint
1 December 2026
1 December 2026

Quick facts

Lead sponsorDuke University
StatusSuspended
Study typeOBSERVATIONAL
Enrollment900
Start date3 December 2019
Primary completion1 December 2026
Estimated completion1 December 2026
Sites1 location across United States

Conditions studied

Sponsor

Duke University

Who can join

Adults 18 to 85, any sex, with Spinal Tumor or Spinal Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary goal of this registry is to increase the knowledge about spine tumors and other spine disorders to guide appropriate management strategies for the future. This registry will include the review of medical records, data collection for health related quality of life questionnaires, and collected tissues and samples. The study will require obtaining spinal lesions (tumor, etc.), blood, and bone marrow samples (from non-lesional bone) from selected patients, which will be collected during your surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Spinal Tumor

Currently open trials in the same condition.

Other Duke University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04217525.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing